EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group

HIV Medicine · 2025

DOI: 10.1111/hiv.70070 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift HIV Medicine, 2025. Verfasst von European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group. Hauptthemen laut MEDLINE: HIV Infections, Dideoxynucleosides, Anti-HIV Agents, Tenofovir. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective To compare BMI‐for‐age z ‐score (zBMI) changes in treatment‐experienced children and young people living with HIV aged 6 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDideoxynucleosidesAnti-HIV AgentsTenofovirAdenineWeight GainHumansChildAdolescentMaleFemaleEuropeAlanineYoung AdultCohort StudiesObesityBody Mass IndexAdultCyclopropanesDideoxyadenosineAbacavir

Stichwörter der Autor:innen

HIVchildrentenofovir alafenamidetreatmentweightyoung people

Substanzen

DideoxynucleosidesAnti-HIV AgentsTenofovirAlanineAdenineCyclopropanesDideoxyadenosineAbacavirtenofovir alafenamide

Förderung

  • Gilead Sciences
  • Medical Research Council

Zitieren

APA

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group (2025). Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe. HIV Medicine. https://doi.org/10.1111/hiv.70070

Vancouver

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group. Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe. HIV Medicine. 2025. doi:10.1111/hiv.70070

BibTeX
@article{EuropeanPregnancyandPaediatricInfectionsCohortCollaborationEPPICCStudyGroup2025,
  author = {European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group, European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group},
  title = {Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe},
  journal = {HIV Medicine},
  year = {2025},
  doi = {10.1111/hiv.70070}
}
Kostenlos starten →